Clinical Trials for Ipilimumab

3 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
OtherVICCMEL12117
02/18/2013
A Multi-Site Retrospective Observational Study of US Patients with Unresectable or Metastatic Melanoma Receiving Ipilimumab (YERVOY?) as First-Line Therapy
TreatmentVICCPHI1359
12/03/2013
A Phase 1/2, Open-label Study of Nivolumab Monotherapy or Nivolumab combined with Ipilimumab in Subjects with Advanced or Metastatic Solid Tumors
TreatmentVICCTHN1189
12/14/2012
Randomized, Multicenter, Double-Blind, Phase 3 Trial Comparing the Efficacy of Ipilimumab plus Etoposide/Platinum versus Etoposide/Platinum in Subjects with Newly Diagnosed Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC)

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.